Become a member for only $5
Automatically entered for complimentary ASCS in your area!
DermDetect has developed a new and improved method of skin cancer screening that is way better than free!
DermDetect has joined with the Oregon Health & Science University (OHSU) Knight Cancer Institute to advance skin cancer research as part of research collaboration. With your OHSU consent, you can easily donate your Advanced Skin Cancer Screening (ASCS) data to OHSU’s research efforts. The collaboration’s goal is to collect data from over 100,000 consenting recipients of ASCSs in a groundbreaking effort focused on early detection of skin cancer to improve survival rates. ASCS is 100% safe and easy! Use our convenient locations to schedule your 20-minute appointment. You get the APP for free and OHSU reviews your case in our secure cloud. Your doctor can also access our cloud to see your results. The report tells you if you need to see your local Dermatologists. SUBSCRIBE NOW
Way better than free skin cancer screening!
Ready to find out more?
Sign up for our newsletter and we will email you when we are in your area.
We Help Find It Early
DermDetect is revolutionizing the way skin cancer is detected in America. We combine state of the art technology and expert dermatology to accurately image, analyze, store, identify, and review irregularities of the skin. We help find melanoma, basal cell, and squamous cell carcinoma at their earliest stages, the key factor to improve outcomes.
Am I at risk of skin cancer?
Find out here by taking this easy quiz provided by the Skin Cancer Foundation
Melanoma Risk Predictor
The Melanoma Risk Predictor is not intended to be used as a substitute for your doctor's advice. You should always consult your doctor if you think you might be at risk, particularly if you have noticed a new or changed skin lesion.
ASCS applauds the researchers in Queensland. The Health History Questionnaire you complete with the ASCS may allow researchers in the USA to develop these type of useful tools. Our research will result in a first-ever database that includes DICOM ELM and clinical images, pathology results and participant's health history and risk factors.